76 related articles for article (PubMed ID: 10528439)
1. [Development of cancer chemotherapy. Discovery of new active drugs. IV].
Lopez M
Clin Ter; 1999; 150(3):241-9. PubMed ID: 10528439
[No Abstract] [Full Text] [Related]
2. [Derivatives of camptothecin. A new class of antineoplastic agents].
Astoul C; Ollitrault N; Salvat D
Soins; 1997 Dec; (621):37-40. PubMed ID: 9479219
[No Abstract] [Full Text] [Related]
3. FDA approves irinotecan as first-line therapy for colorectal cancer.
Oncology (Williston Park); 2000 May; 14(5):652, 654. PubMed ID: 10853457
[No Abstract] [Full Text] [Related]
4. [Ovarian cancer. The new chemotherapeutic agents].
Catimel G; Talon A
Soins; 1995 Oct; (599):20-2, 24-5. PubMed ID: 8701349
[No Abstract] [Full Text] [Related]
5. New options for the treatment of advanced ovarian cancer.
Dunton CJ
Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-2-S5-11. PubMed ID: 9122739
[TBL] [Abstract][Full Text] [Related]
6. New chemotherapeutic agents in non-small-cell lung cancer.
Feigal EG; Christian M; Cheson B; Grever M; Friedman MA
Semin Oncol; 1993 Apr; 20(2):185-201. PubMed ID: 7683142
[No Abstract] [Full Text] [Related]
7. New cytotoxic drugs in clinical development.
Extra JM; Rousseau F; Culine S; Giacchetti S; Madelaine I; Marty M
Nouv Rev Fr Hematol (1978); 1991; 33(6):451-6. PubMed ID: 1687829
[No Abstract] [Full Text] [Related]
8. Irinotecan for metastatic colorectal cancer.
Med Lett Drugs Ther; 1997 Jan; 39(992):8. PubMed ID: 9008684
[No Abstract] [Full Text] [Related]
9. Irinotecan and other agents in upper gastrointestinal and colorectal carcinomas. The University of Texas M. D. Anderson Cancer Center Investigators' Workshop, Volume 3. Introduction.
Ajani JA
Oncology (Williston Park); 2003 Sep; 17(9 Suppl 8):10-2. PubMed ID: 14569840
[No Abstract] [Full Text] [Related]
10. Efficacy and safety of topotecan in the treatment of advanced ovarian carcinoma.
ten Bokkel Huinink W; Carmichael J; Armstrong D; Gordon A; Malfetano J
Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-19-S5-25. PubMed ID: 9122738
[TBL] [Abstract][Full Text] [Related]
11. Whither irinotecan?
Blanke CD
J Clin Oncol; 2005 Aug; 23(22):4811-4. PubMed ID: 15939928
[No Abstract] [Full Text] [Related]
12. [New drugs. Topoisomerase inhibitors].
Gutzler F
Zentralbl Gynakol; 1996; 118(10):579. PubMed ID: 8999716
[No Abstract] [Full Text] [Related]
13. Third Wave, Daiichi to develop personalized cancer treatment.
Expert Rev Mol Diagn; 2002 Jan; 2(1):6. PubMed ID: 11963807
[No Abstract] [Full Text] [Related]
14. Clinical trials referral resource. Trials of topotecan.
Cheson BD; Phillips PH; Arbuck SG
Oncology (Williston Park); 1995 Mar; 9(3):220, 224-6, 228. PubMed ID: 7669515
[No Abstract] [Full Text] [Related]
15. Irinotecan may extend survival in people with metastatic colorectal cancer.
Oncology (Williston Park); 1998 Oct; 12(10):1512. PubMed ID: 9798204
[No Abstract] [Full Text] [Related]
16. Clinical trials referral resource. Clinical trials with topotecan.
Cheson BD; Arbuck SG
Oncology (Williston Park); 1993 Feb; 7(2):49-51. PubMed ID: 8439468
[No Abstract] [Full Text] [Related]
17. Nothing succeeds like failure.
Nat Biotechnol; 2002 Feb; 20(2):101. PubMed ID: 11821837
[No Abstract] [Full Text] [Related]
18. Irinotecan for colorectal cancer: a small step forward.
O'Connell MJ
Lancet; 1998 Oct; 352(9138):1402. PubMed ID: 9807982
[No Abstract] [Full Text] [Related]
19. Front-line paclitaxel and topotecan chemotherapy in advanced or metastatic non-small-cell lung cancer: a phase II trial.
Stathopoulos GP; Katis C; Tsavdaridis D; Dimitroulis J; Karaindros D; Stathopoulos J; Dimou E
Cancer Chemother Pharmacol; 2006 Oct; 58(4):555-60. PubMed ID: 16520987
[TBL] [Abstract][Full Text] [Related]
20. ImClone BLA is declined.
Fletcher L
Nat Biotechnol; 2002 Feb; 20(2):111. PubMed ID: 11845796
[No Abstract] [Full Text] [Related]
[Next] [New Search]
